ERG and cancer: In addition, C-MYC was added for the following reasons: i) C-MYC overexpression has been noted in CaP previously [78, 85-87]; ii) AAbs against C-MYC have been noted in breast and other cancers [88]; iii) Analysis of VCaP cells, charcoal stripping followed by R1881 treatment, showed a close correlation between ERG and C-MYC [79].